SP-CHE-010-1
NODAGA-cyclo(RGDyK) - Radioligand, precursor for radiolabeled NODAGA-cyclo(RGDyK) and with high affinity to GRPR, SSTR2, and MC1R receptors. Can be bound to radionuclides for development of cancer treatment and diagnosis. For research use only!
We provide the peptide in a range of aliquot sizes, ensuring flexibility for diverse research applications. For any special requirements, please contact our customer support: peptide@jpt.com
One focus of JPT’s product development is oncology. Therefore, we offer a huge variety of TAA peptide, peptide pools and microarrays, as well as <DOTA peptides and radio sensitizers. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.Have a look at our Peptide Tools to Study Cancer.
Benefits of JPT's Single Catalogue Peptides
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
References:
Read References with Specialty Peptides
| Properties | Values |
|---|---|
| Application: | Nuclear medicine |
| Category: | Chelate Peptides (DOTA) |
| Condition / Topic: | Cancer |
| Layout: | Freeze-dried in plastic vial |
| Organism: | Artificial |
| Protein Name: | Other |
| Purity: | >95% (HPLC-MS) |
| Quantification: | No |
| Information | Values |
|---|---|
| Sequence: | RGD-DTyr-Lys(NODAGA), head-to-tail cyclized |
Check our list of products, click and go.
Get a quote